Northern Trust Corp Immuno Precise Antibodies Ltd. Transaction History
Northern Trust Corp
- $586 Billion
- Q2 2024
A detailed history of Northern Trust Corp transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 50,730 shares of IPA stock, worth $33,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,730
Previous 53,950
5.97%
Holding current value
$33,989
Previous $82,000
37.8%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.66MCall Options Held
14.1KPut Options Held
6.9K-
Ingalls & Snyder LLC New York, NY1.3MShares$867,9450.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.9KShares$42,8190.0% of portfolio
-
Bank Of Montreal Toronto, A655.9KShares$37,4240.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$27,6040.0% of portfolio
-
Federation Des Caisses Desjardins Du Quebec Levis, A827KShares$18,1120.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $16.6M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...